About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Dietary Impact on Continuous Glucose Monitoring | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT05845827

Dietary Impact on Continuous Glucose Monitoring

Cardiorespiratory fitness (CRF), also known as "exercise capacity", is the capacity of respiratory and circulatory systems to supply oxygen to skeletal muscle during exercise for the generation of ene...

Lead sponsor: Dartmouth-Hitchcock Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Dartmouth-Hitchcock Medical Center

Age

14 - 22 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adolescents and young adults, ages 14-22 years

Exclusion Criteria

•Previous diagnosis of type 1 or 2 diabetes
•Previous diagnosis of hyperlipidemia or other metabolic disease
•Use of medications known to affect glucose metabolism (metformin, oral steroids, sulfonylureas, insulin).
•Allergies to milk.
•Inability to participant in the maximal exercise test on the treadmill.
•Individuals not having android or IOS phones
•Individuals who cannot speak and/or write in English.

Related studies

Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes

NCT05543083 · Insulin Resistance, Depression, and more

Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)

NCT06956781 · PTSD, Trauma, and more

Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring

NCT06867289 · Procedural Sedation and Analgesia, Pediatric ALL

RECRUITINGPhase 1

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

NCT07257419 · Relapsed Pediatric ALL, Hematopoietic Cell Transplantation, and more

RECRUITINGPhase 1/2

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

NCT06575426 · Diabetes Mellitus, Type 1, Hypoglycemia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 29, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment30

Start dateJun 2023

Last updatedFeb 29, 2024

Condition

Glucose Metabolism Disorders Dietary Habits Pediatric ALL Adult ALL

Locations shown

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 29, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions